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Abstract
The drug cisplatin has broad antineoplastic activity against advanced testicular and ovarian cancers, epithelial
malignancies, cancers of the head, neck, bladder, oesophagus and lungs. Peripheral neurotoxicity, ototoxicity and
nephrotoxicity are its major side effects. The nonspecific action of this drug on the lipid bilayer architecture of membranes
has been studied by following the effects produced on the electrical characteristics of model planar bilayer lipid membranes
(BLM). The results confirm that the drug has a strong surface interaction with the zwitterionic polar head groups of the
amphipathic phospholipids constituting the BLM. The permeability characteristics of cisplatin through the hydrophobic core
are limited. Cisplatin does not fluidise the membrane sufficiently to cause its breakdown but creates small ion conducting
defects on the membrane bilayer resulting in a marginal increase in ion conductivity. These results indicate that cisplatin
exhibits a non-specific action on the lipid bilayer component of the membrane which might be partly responsible for its
neurotoxic side effects. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The accidental ¢nding of the cytotoxic e¡ect of
cisplatin has led to the investigation of several
Pt(II) and Pt(IV) four and six coordination com-
plexes for their chemotherapeutic potencies against
solid tumours [1^5]. Cisplatin, carboplatin, oxalipla-
tin and a few other platinum complexes are currently
administered in the treatment of testicular and ovar-
ian cancers. Their interference with DNA synthesis
and cell division by forming an adduct with DNA
molecules has been well established [5^8]. Nausea,
vomiting, sensory neuropathy and ototoxicity are
the reported neurological side e¡ects of cisplatin
[9^11]. At higher doses, cisplatin causes peripheral
neuropathy too but there is no evidence for central
nervous system impairment [3]. Its suppressive sym-
pathetic neuronal activity is evident from its reported
action on adrenal chroma⁄n cells [12]. Cisplatin in-
duced inhibitory action on resting leak conductance,
transient depolarisation linked increase in conduc-
tance and enhancement of excitability by reducing
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Abbreviations: BLM, bilayer lipid membrane; PC, phosphati-
dylcholine; PE, phosphatidylethanolamine; AC, alternating cur-
rent; DC, direct current; RMS, root mean square; LCZ meter,
inductance (L), capacitance (C) and impedance (Z) meter; CEC,
Capital Equipment Corporation; IEEE, industrial standard also
called general purpose interface bus (GPIB), a standard cable and
protocol for connecting measurement devices to computers
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the threshold potential have been reported from elec-
trophysiological patch clamp studies on cultured dor-
sal root ganglion neurones [13]. Cisplatin has been
reported to attenuate voltage activated potassium
and calcium current and thus interferes with Ca2
activated chloride channels [9]. Interaction of cispla-
tin with membrane constituents could have modi¢ed
the ion channel activity [11].
Earlier studies on neuroactive compounds such as
insecticides, anaesthetics, tranquillisers, antidepres-
sants, etc., have suggested a strong involvement of
a nonspeci¢c impeding action of these compounds on
the lipid bilayer in their neurological e¡ects. Popular
insecticides like parathion, malathion, lindane, DDT
and allethrin induce perturbations of membrane per-
meability and £uidise the membrane and the changes
could be partially related to their primary insecticidal
activity [14^16]. The major cause of the sedative side
e¡ect of the antidepressant imipramine has been at-
tributed to its ability to penetrate membrane struc-
tures [17]. Studies on anaesthetics like halothane and
en£urane have proved that the preferred position of
interaction of inhalation anaesthetics with the lipid
bilayer is the membrane interface [18,19]. E¡ects of
alcohols on proton and potassium permeability of
lipid bilayers have been qualitatively related to their
anaesthetic activity [20]. The e¡ect of amphiphilic
drugs might be due to their interaction with the polar
head groups of the membrane lipid bilayer [21].
These results give rise to the question whether the
neurotoxic side e¡ects of cisplatin could be due to
a similar nonspeci¢c interaction with the lipid bilayer
component of membranes. According to some recent
reports, cisplatin interacts with both cellular and
model membranes involving acidic lipid constituents
[22,23] and also with zwitterionic lipid rich azolectin
model membranes, changing its resistance, surface
tension and boundary potential [4]. Neuronal impair-
ment could be due to electrochemical changes both
at the membrane surface and at the inner core of the
neuronal membrane. However, in spite of the signi¢-
cance of cisplatin interaction with membrane compo-
nents, studies on cisplatin induced e¡ects on model
membranes simulating the lipid bilayer have been
scanty [13,22]. Considering these facts, investigatory
studies on cisplatin induced changes in the surface
and interior electrical characteristics of bilayer lipid
membrane (BLM) have been undertaken. Further,
entry of cisplatin into target and nontarget tissues
has been reported to be largely di¡usional passage
without the involvement of membrane associated
proteins by some workers [3,5,12] and facilitated
transport with the involvement of in£ux and e¥ux
proteins by others [6]. So, the proposed study of non-
speci¢c action of cisplatin on BLM could help to
understand the in vivo permeability features of cis-
platin.
The trans isomer of cisplatin (transplatin) report-
edly possesses much less antitumour activity
[3,11,13]. Therefore, it does not ¢nd widespread use
in chemotherapy. Hence the focus of this study was
on the more active and neurotoxic cisplatin.
2. Materials and methods
Phospholipid mix from hen’s egg yolk was isolated
following standard procedure [24]. Thin layer chro-
matography using a chloroform^methanol^acetic
acid^water solvent system [24] in the ratio
25:15:4:2 was carried out on a glass plate spread
with silica gel adsorbent containing calcium sulphate
binder. The chromatogram, developed using iodine
vapours and also standard phosphate stain [25],
showed three distinct spots con¢rming the heteroge-
neity of the phospholipid mix. Earlier workers have
shown that egg phospholipids contain a predominant
fraction of phosphatidylcholine (PC) (74%) and
phosphatidylethanolamine (PE) (15%) with lysophos-
phatides, sphingomyelin, plasmalogen and phospha-
tidylinositol as the minor ingredients [25]. The un-
fractionated phospholipid stock in chloroform (50
mg/ml) stored in nitrogen environment was dispersed
in n-decane (2.5% w/v) after the evaporation of
chloroform. This dispersion was prepared on a daily
basis to form BLM.
A polymethyl methacrylate chamber with two 5 ml
aqueous compartments divided by a 1 mm thick sep-
tum was used for the experiments. BLM was formed
by a syringe (painting method) on a 1.2 mm diameter
aperture made in the septum [26]. Electrical contact
was through two non-polarisable Ag/AgCl/Cl3 elec-
trodes made following standard procedures [27]. The
BLM unit was mounted on a vibration-free platform
and provided with electrical shielding to avoid stray
current pick-up [28].
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Aqueous unbu¡ered molar, decimolar and centi-
molar solutions of NaCl (E. Merck, India) with a
pH around 7.0 and standard bu¡er solutions
[24,25] of pH 6.0 and 7.0 containing 10 mM, 100
mM and 1000 mM NaCl constituted membrane
‘bathing’ media. The stabilisation of the membrane
took about 10^30 min as evident from the recorded
steady electrical characteristics. Cisplatin, procured
from Dabur Research Foundation (India), was
added in the aquated form in known micromolar
quantities from an aqueous stock solution (0.5 mg/
ml) prepared from chloride-free water. The drug was
added in small aliquots up to a maximum cisplatin
dose of 100 WM which is 10 times the reported clin-
ically relevant dose [11].
The DC electrical characteristics such as conduc-
tance and capacitance were measured using the dig-
ital Keithley electrometer (Model 6517, USA) with
IEEE interface and CEC test point data acquisition
software. The AC characteristics were studied using a
digital LCZ meter (Model 1061, Chen-Hwa, Taiwan)
capable of applying 0.01^1.0 V at an increment of
10 mV. Applied frequency was varied in 30 steps
from 40 Hz to 200 kHz. The capacitance, impedance
and the phase angle di¡erence of BLM were meas-
ured in both parallel and series modes. The capaci-
tance, impedance and conductance are reported per
unit area assuming that the membrane covers the
entire aperture (1.2U1032 cm2). All the studies
were done between 22 and 24‡C.
It is a well-established fact that the electrical char-
acteristics of BLM vary from one membrane to an-
other [26,28,30,34]. Hence each experiment was re-
peated 5^7 times and the results presented are the
mean values from these experiments. The variation
in the electrical characteristics from one membrane
to another was well within 10%.
3. Results
It is well established that the BLM with its hydro-
phobic core and polar head groups acts as an organic
capacitator [29]. The dose dependent interaction of
cisplatin on the AC capacitance of BLM at a con-
stant applied RMS voltage of 40 mV and an applied
frequency of 40 Hz in di¡erent ionic strengths of
NaCl is presented in Fig. 1. Initially, a steep increase
in capacitance was noted in all concentrations of
NaCl (0.01 M, 0.1 M and 1.0 M). The capacitance
then reached a saturation value above a cisplatin
Fig. 1. Dose dependent change in AC capacitance by cisplatin
in 0.01 M NaCl (b), 0.1 M NaCl (a) and 1.0 M NaCl (U) at
an applied RMS voltage of 40 mV and an applied frequency of
40 Hz.
Table 1
Dose dependent change in AC capacitance in bu¡ered and unbu¡ered media containing 10 mM and 100 mM NaCl
Cisplatin dose (WM) Membrane capacitance
10 mM NaCl 100 mM NaCl
Unbu¡ered Bu¡ered Unbu¡ered Bu¡ered
0 0.1116 0.1177 0.1096 0.1262
20 0.1414 0.1482 0.1602 0.1752
40 0.1436 0.1490 0.1744 0.1871
60 0.1426 0.1481 0.1733 0.1913
80 0.1452 0.1475 0.1749 0.1993
100 0.1418 0.1488 0.1737 0.1994
The unit of speci¢c capacitance is WF/cm2.
The readings were taken at an applied RMS voltage of 40 mV and an applied frequency of 40 Hz.
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concentration of 20 WM in 0.01 M NaCl and above
40 WM in 0.1 M NaCl. However, in 1.0 M NaCl bath
medium, an initial steep increase in capacitance was
observed up to doses of 20 WM which was followed
by a sublinear increase for cisplatin doses up to
100 WM. The increase in capacitance was found to
be maximal in 1.0 M NaCl and least in 0.01 M NaCl
medium. Thus it is apparent that the ionic strength
of the bath medium has a bearing on the cisplatin-
BLM interaction.
Experiments with bu¡ered solutions (pH 7.0) con-
taining 10 mM, 100 mM and 1000 mM NaCl showed
similar trends and the results are presented in Table
1.
Another important observation relates the extent
of interaction of cisplatin when added symmetrically
on both sides of the membrane and when it is added
asymmetrically to the cis side only. The hydrostatic
pressure developed due to unequal volumes on either
side during asymmetric addition was o¡set by addi-
tion of an equal volume of distilled water on the
trans side. Regardless of the mode of addition of
cisplatin and ionic strength of the medium, an in-
crease in capacitance was noted in all cases. From
Fig. 2, it is seen that the per cent increase in capaci-
tance, under similar conditions of applied RMS volt-
age and frequency, produced due to the addition of
100 WM cisplatin is considerably higher than that
produced when the same quantity of cisplatin is
added asymmetrically.
Fig. 2. E¡ect of symmetric and asymmetric modes of drug ad-
dition on the per cent increase in AC capacitance at an RMS
voltage of 40 mV and an applied frequency of 40 Hz. Striped
boxes indicate asymmetric addition and dotted boxes represent
symmetric addition.
Fig. 3. Admittance^capacitance pro¢le at 40 mV (RMS) in
0.01 M NaCl (a), 0.1 M NaCl (b) and 1.0 M NaCl (U).
Fig. 4. Frequency dependent dispersion at 40 mV (RMS) of
control (b) and drug infested (U) membranes in 0.01 M NaCl.
The drug load is 100 WM in either compartment.
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A plot of membrane admittance against membrane
capacitance in NaCl bath media of di¡erent ionic
strengths at 40 mV (RMS) and 40 Hz (Fig. 3) with
cisplatin doses as the variant was linear. It is inter-
esting to note that the linearity was not shifted in
di¡erent strengths of NaCl, but the area under the
curve increased with increasing NaCl concentration
in the ratio of 1:4:10.
The frequency dependent dispersion of the mem-
brane capacitance at a constant RMS voltage of
40 mV was studied in 0.01 M NaCl and 1.0 M
NaCl for the bare membrane and membrane infested
with 100 WM cisplatin. A Maxwell^Wagner type of
dispersion occurred in both cases [30]. 100 WM was
chosen because it is expected from the study of dose
dependent change in capacitance (Fig. 1) that the
maximum interaction in 1.0 M NaCl bath medium
would be recorded at that dose while for 0.01 M
NaCl, the saturation level would have been attained
at the same dose. In 0.01 M NaCl, the frequency
dependent dispersion pattern was observed to be
the same for the BLM in the control and drug in-
fested conditions. A small di¡erence of 100 pF was
maintained at all frequencies studied (40 Hz^200
kHz) as shown in Fig. 4 whereas in the 1.0 M
NaCl medium, the capacitance curve for the bare
and drug infested membranes synchronised above
the applied frequency 60 kHz. But up to 60 kHz,
the drug infested membrane maintained a higher ca-
pacitance (Fig. 5).
The trends obtained in the AC mode of operation
were similar to those obtained in the DC capacitance
Fig. 5. Frequency dependent dispersion at 40 mV (RMS) of
control (b) and drug infested (U) membranes in 1.0 M NaCl.
The drug load is 100 WM in either compartment.
Fig. 6. Charge^decay pro¢les for control (solid lines) and drug infested (dotted lines) at 40 mV (DC) in 0.01 M NaCl (a), 0.1 M
NaCl (b) and 1.0 M NaCl (U). 100 WM cisplatin is added to either compartment. The series resistance used for measurement in all
cases is 1 G6.
BBAMEM 77733 26-1-00
K.U. Maheswari et al. / Biochimica et Biophysica Acta 1463 (2000) 230^240234
studies. The DC capacitance was measured using the
charge decay method [26]. We observed that the
charging potential and the decay time depended on
the membrane conductance and capacitance. The ad-
dition of cisplatin to the bath medium was found to
alter both the charging potential and the time con-
stant. As observed with the AC studies, the e¡ect
was most pronounced in 1.0 M NaCl and least in
0.01 M NaCl with the value in 0.1 M NaCl inter-
mediate between the two. Fig. 6 summarises the ef-
fects produced by 100 WM cisplatin on the charging
potential and time constant of the BLM in di¡erent
NaCl media.
The cisplatin dose dependent change in membrane
conductance also appears to be controlled by the
ionic strength of the medium. The magnitude of in-
crease in DC conductance due to loading of increas-
ing doses of cisplatin was extremely small in the
0.01 M NaCl medium while it was considerable in
1.0 M NaCl and intermediate in 0.1 M NaCl. The
plot of membrane capacitance against membrane
conductance in di¡erent concentrations of NaCl fol-
lowed a linear trend. However, the slope of the linear
lines increased with increasing ionic strengths of the
bath medium in the ratio 1:5:10. Fig. 7 shows the
conductance^capacitance plot obtained at 40 mV
(DC) in 1.0 M NaCl bath medium.
One common observation in all measurements per-
taining to the dose dependent interaction of cisplatin
with the BLM was that it took about 22^25 min for
the drug^membrane interaction to take place, as was
evident from the electrical measurements.
The dielectric strength of the BLM was not altered
signi¢cantly by the addition of cisplatin as the break-
down voltage of the bare and drug infested mem-
branes was found to fall in the same range in all
bath concentrations of NaCl. Fig. 8 displays a plot
of the voltage dependent dispersion of capacitance at
40 Hz for bare and drug infested membranes in 1.0 M
NaCl. Both curves show a slight biphasic nature at
lower voltages.
4. Discussion
The ¢rst part of the BLM the drug encounters is
the polar head groups of the amphipathic lipids con-
stituting the BLM. Cisplatin, being hydrophilic, is
more likely to accumulate at the membrane^solution
interface. The chemistry of cisplatin is typical of a
platinum coordination complex. cis-Dichlorodiam-
mine platinum(II) or cisplatin is a four coordinated
square planar complex. When cisplatin is dissolved in
Fig. 7. Dose dependent capacitance^conductance pro¢le of
BLM at 40 mV (DC) in 1.0 M NaCl bath medium. The series
resistance used for the capacitance measurements is 100 M6.
Fig. 8. Voltage dependent dispersion of membrane AC capaci-
tance for control (b) and drug infested (U) membranes at an
applied frequency of 40 Hz. The drug load in either compart-
ment is 80 WM.
BBAMEM 77733 26-1-00
K.U. Maheswari et al. / Biochimica et Biophysica Acta 1463 (2000) 230^240 235
chloride-free water, the following aquation reactions
take place:
PtCl2NH32 H2O! PtClH2ONH32  Cl3
1
PtClH2ONH32 H2O!
PtH2O2NH322  Cl3 2
PtCl2NH32  2H2O! PtH2O2NH322  2Cl3
3
The water medium can also supply hydroxo li-
gands which can take part in the aquation reactions.
PtCl2NH32 OH3 ! PtClOHNH32  Cl3
4
PtClOHNH32 OH3 !
PtOH2NH32  Cl3 5
PtH2O2NH322 OH3 !
PtOHH2ONH32 H2O 6
It is a well-established fact that it is generally eas-
ier to replace a chloride ligand bound to Pt(II) than
other ligands [31]. The rate constants for Eqs. 1^3
are reported to be 1.78U1033 s31, 2.75U1034 s31
[22,23] and 7.2U1037 s31 [5] respectively. Since
NH3 ligand occupies a higher place in the spectro-
chemical series than both Cl3 and H2O [32], replace-
ment of NH3 ligand does not take place under mild
reaction conditions. The formation and existence of
the monopositive and dipositive forms of cisplatin
have been reported and well established in coordina-
tion chemistry [31] as well as in the intracellular me-
dium where the chloride concentration is less than
100 mM [5,22].
When the system is supplied with an excess of
chloride ions, the equilibrium is shifted towards the
left and the reverse anation reactions take place [31].
The greater the number of chloride ions, the more
feasible will be the formation of the neutral species.
In the present experiments, cisplatin was added
from a stock solution which contained a mixture of
all the above species. When cisplatin was added to
the bath medium containing chloride ions, the re-
verse anation reactions occurred leading to the for-
mation of the neutral dichloride and hydroxochloride
forms depending on the availability of chloride ions
in the medium. The pH of the unbu¡ered bath me-
dium did not change drastically on addition of cis-
platin and continued to be around neutral pH (7.0).
At this neutral pH, Speelmans et al. have reported
that the major species of cisplatin are the uncharged
dichloride and hydroxochloride forms [22,23]. How-
ever, at lower chloride concentrations such as those
in 0.01 M NaCl bath medium, a small amount of the
charged monopositive form of cisplatin (about 20%)
also exists [22,23]. The charged forms will be virtu-
ally absent in the 1.0 M NaCl bath medium where
there is a large quantity of chloride ions available to
facilitate the faster formation of the dichloride spe-
cies. Reports of the existence of the neutral form of
cisplatin in the blood stream where the chloride con-
centration is above 100 mM [5] further con¢rm these
reactions.
The observed di¡erences in the electrical properties
of bare and drug infested membranes could be ex-
plained based on the drug induced e¡ects on the ion
conductance and the electrical double layer at the
membrane-solution interface and also on the avail-
ability of the neutral dichloride form of cisplatin in
the bath medium.
The polar head groups of the BLM act as charged
plates of a capacitator enclosing the hydrophobic
core which acts as a dielectric and is responsible
for the capacitative nature of the BLM [26]. The
polar head groups attract counterions from the aque-
ous bath medium resulting in the formation of an
electrical double layer which is a well-documented
phenomenon at any membrane^solution interface
[30]. When the drug is added to the bath medium,
the various forms of the drug (dichloride, hydroxo-
chloride and the monopositive species) initially come
into contact with the polar head groups and the
counterion array. The neutral cisplatin molecule (ei-
ther the dichloride or the hydroxochloride form) in
the bath medium, being non-polar and non-conduct-
ing, might become entrapped between the electrical
double layers thus acting as a dielectric sandwiched
by two charged plates. This mini-capacitator will
contribute to the total capacitance of the system re-
sulting in the observed rise in capacitance. The for-
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mation and existence of the neutral form of cisplatin
being maximum and the availability of a large num-
ber of ions at the membrane^solution interface to
form the electrical double layer in the 1.0 M NaCl
medium may explain the maximum increase in ca-
pacitance observed in this medium.
In 0.01 M NaCl bath medium, the number of ions
available at the membrane^solution interface is
smaller. Also, the presence of a few monopositive
species of cisplatin reduces the number of neutral
cisplatin molecules available for the formation of
the dielectric sandwich at the membrane^solution in-
terface. The overall result is that there is an increase
in the capacitance of the BLM due to a surface in-
teraction of cisplatin but this increase is smaller than
those observed in 0.1 M and 1.0 M NaCl media.
Experiments carried out in bu¡ered solutions of pH
7.0 containing 10 mM, 100 mM and 1000 mM NaCl
also displayed similar trends. The results are pre-
sented in Table 1. Interaction of cationic forms of
cisplatin with the acidic lipids phosphatidylserine and
phosphatidic acid and isolation of such adduct prod-
ucts [22,23] have been reported earlier. The present
experiments con¢rm that the drug also interacts with
neutral zwitterionic lipids.
In 1.0 M NaCl, the interaction with the BLM sur-
face progressively increases with added doses of cis-
platin. It indicates that the binding sites on the mem-
brane surface are relatively free of any adsorbed
species, namely the charged form of cisplatin. This
is similar to the results reported on the interaction of
the neutral form of pentachlorophenol with phos-
pholipid bilayers [33]. In 0.01 M NaCl bath medium,
though the neutral species of cisplatin predominates,
the charged form of cisplatin interacts electrostati-
cally with the zwitterionic polar head groups of the
BLM and the capacitance values soon become satu-
rated. The onset of saturation in 0.1 M NaCl, where
the number of ions in the bath medium is relatively
greater, occurs at a higher dose of cisplatin. Since no
experiments were carried out beyond 100 WM cispla-
tin concentration, possible saturation of capacitance
values beyond the addition of 100 WM cisplatin in the
1.0 M NaCl medium could not be recorded.
The asymmetric addition of the drug results in a
smaller change in capacitance than symmetric addi-
tion. This clearly indicates restricted permeability of
cisplatin through the lipid bilayer. The di¡erence in
the percentage capacitance during symmetric and
asymmetric addition rules out the possibility of the
increase in capacitance being due to a change in the
area or thickness of the BLM.
It is interesting to note that the per cent increase of
capacitance in 0.01 M NaCl during symmetric addi-
tion is double that observed during asymmetric ad-
dition while it is nearly 1.8 times in 0.1 M NaCl and
1.4 times in 1.0 M NaCl. This shows that cisplatin
has very low permeability through the membrane
and hence the asymmetric addition produces approx-
imately only half the e¡ect on the increase in capaci-
tance of symmetric addition. The possibility of for-
mation of an additional capacitator on the trans
side of the BLM is ruled out due to lack of drug
molecules in the trans side during asymmetric addi-
tion.
In 0.01 M NaCl medium, the charged forms of
cisplatin become anchored on the membrane surface
by electrostatic attraction with the charged polar
head groups of the BLM. Since cisplatin does not
have any lipophilic end, its penetration into the lipid
bilayer is not possible. Thus, in biological systems,
in£ux of the charged form of cisplatin may involve a
carrier protein. Such carrier proteins for in£ux and
for rapid e¥ux in drug resistant cell lines have al-
ready been reported [8].
However, the permeability of the neutral form of
cisplatin, which is the predominant form at neutral
pH, through the BLM is feasible as generally neutral
molecules are reported to possess greater permeabil-
ity through the BLM than charged forms [34]. More-
over, as the concentration of the bath medium in-
creases, some small ion conducting defects are
formed on the compact bilayer architecture due to
the additives (drug) as well as the number of ions in
the medium, resulting in greater ionic £ux [20,26].
Neutral cisplatin, being small, could squeeze through
these defects in the BLM and reach the other side.
This may explain the slightly higher per cent increase
in capacitance in 0.1 M and 1.0 M NaCl bath media
during asymmetric addition than the expected value
which is half the increase observed during symmetric
addition. As the number of ions is maximal in the 1.0
M NaCl medium, the deviation from the expected
per cent increase during asymmetric addition is also
maximal (expected: 50%, observed: 66%). These re-
sults indicate that neutral cisplatin might also serve
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as an interstitial and substitutional impurity for the
acyl chain core of the BLM.
Admittance is a function of capacitance at con-
stant applied frequency and hence the plot of admit-
tance vs capacitance (Fig. 3) is linear. However, the
dose dependent admittance-capacitance pro¢les of
cisplatin in 0.01 M, 0.1 M and 1.0 M NaCl media
all fall on the same line indicating that the mode and
site of interactions of cisplatin on the BLM are the
same regardless of the concentration of the bath me-
dium. The linear relation between drug induced
change in membrane capacitance and admittance in
all NaCl media (0.01 M, 0.1 M and 1.0 M) with the
same slope con¢rms the better interaction of neutral
cisplatin. The di¡erence in the areas under the curve
in the three bath media may be attributed to the
amount of the neutral form of cisplatin and to the
number of ions present in the bath medium and to
the number of drug induced ion conducting defects
created on the membrane matrix.
The observed large increase in membrane capaci-
tance in 1.0 M NaCl medium may be partly due to
the interior capacitance besides the surface capaci-
tance [18,19]. But accommodated cisplatin with the
bilayer core enhanced conductance but not inner ca-
pacitance. This is evident from the results depicted in
Fig. 5. Generally, surface barriers for the entry of
ions and polar molecules are relieved at higher fre-
quencies [30]. In 1.0 M NaCl medium, the control
and drug infested membranes show signi¢cant di¡er-
ences in capacitance initially. But at high frequencies
(s 6U104 Hz), both curves converge indicating that
the control and drug infested membranes have the
same inner core capacitance. Thus the observed large
increase of membrane capacitance is exclusively due
to surface interaction. It could be concluded that the
same dielectric loss mechanisms dominate the disper-
sion behaviour in both cases at high frequencies as
has been reported for neutral pentachlorophenol [33].
In the 0.01 M NaCl medium, the electrostatic in-
teraction of the small amount of monopositive cis-
platin present in the medium with the polar head
groups of the BLM interferes with the e¡ective re-
lieving of surface barriers at higher frequencies re-
sulting in a small di¡erence in capacitance being
maintained throughout the frequency range studied.
The surface interaction of cisplatin is further sub-
stantiated from the voltage dependent dispersion
studies of BLM in the presence of cisplatin, where
irrespective of the charge status of cisplatin, the di-
electric strength of the membrane was not altered
signi¢cantly indicating that the drug does not £uidise
the membrane in the concentration ranges studied.
The linear DC capacitance^conductance plot also
favours an increased interaction of the neutral cispla-
tin over any charged forms. The increase in conduc-
tance with increasing cisplatin dose in 0.01 M NaCl
indicated that the transport of any charged form of
cisplatin through the BLM is minimal. However,
neutral cisplatin, being non-conducting, cannot ac-
count for the observed increase in conductance in
the NaCl bath media. So, the observed increase
must be due to accelerated passage of chloride and
sodium ions through some ion conducting defects
created by the drug in the inner hydrocarbon core.
As the neutral form of cisplatin is predominant
under the experimental conditions, it is more likely
to induce the ion conducting defects on the mem-
brane matrix. As the number of ions is maximal in
1.0 M NaCl, the increase in conductance is also high-
er in this medium than in the lower bath concentra-
tions. However, these defects caused by cisplatin on
the BLM could not be large enough to £uidise the
membrane architecture, which is evident from the
observation that the dielectric strength of the BLM
is not altered by cisplatin. This action of cisplatin is
similar to that reported for the insecticide malathion
with lipid bilayers [15].
The lack of any appreciable change in the dielec-
tric strength of BLM due to cisplatin^BLM interac-
tion could be explained based on the structure of
cisplatin. Cisplatin is a simple, small and planar mol-
ecule whose voltage induced passage through the
BLM or interaction with the polar head groups at
the surface would not cause much perturbation of
the membrane architecture partly because of its com-
pact size and partly due to its relative di⁄culty in
passing through the membrane. Hence, even the pas-
sage of neutral cisplatin does not £uidise the mem-
brane but might only induce minor defects on the
membrane matrix.
The observed voltage induced increase in capaci-
tance of both control and drug infested membranes
could be due to a combination of reduction in BLM
thickness and an increase in the membrane area as
reported by earlier workers [26]. The slight biphasic
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nature of the voltage^capacitance pro¢les proves the
necessity of a threshold voltage to promote the inter-
action of ions and the drug molecules with the mem-
brane [26].
From the electrical characteristics, it could be es-
tablished that the neutral form of cisplatin which is
the predominant form at neutral pH shows the max-
imum tendency to interact with the BLM and in-
creases the membrane capacitance considerably. It
is also evident that the surface interaction of cisplatin
is the dominant mechanism. Since all experiments
were carried out with unmodi¢ed BLMs, the di¡u-
sion controlled passage of the neutral cisplatin
through the lipid bilayer is strongly favoured in ac-
cordance with the reported in vitro and in vivo ob-
servations [3,5,12]. The present study highlights the
fact that cisplatin also interacts with PC and PE
apart from acidic lipids reported by some workers
[22,23].
As discussed earlier in this paper, the neurological
action of cisplatin comprises a nonspeci¢c action on
the lipid bilayer core structure. The present ¢ndings
that cisplatin changes the surface capacitance and
admittance of protein-free zwitterionic BLM in a
dose dependent manner clearly indicate its nonspe-
ci¢c action. Earlier reports that acidic amphiphilic
lipids strongly interact with the charged form of cis-
platin [22,23] are also an observation of nonspeci¢c
action only. These nonspeci¢c actions could initiate
neuronal impairment in cancer patients being treated
with cisplatin thus accounting for its neurotoxic side
e¡ects. As the lipid fraction has been reported to
constitute about 75^80% of the nerve myelin dry
weight [35], cisplatin, which could act on lipid bi-
layers even in the absence of any speci¢c receptor
protein, could possibly accumulate in the lipid rich
nerve tissues resulting in the reported neurotoxicities.
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